Effect of Black cohosh(Cimi fugol) on early symptoms of menopause

Effec of Black cohosh on early symptoms of menopause

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201107186709N4

Enrollment

Registered

2012-01-15

Start date

2012-01-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early symptoms of menopause. Menopausal and female climactric states

Interventions

Intervention 1: Intervention group:They will use oral tablet Cimi fugol daily for 8 weeks ,one tablet after dinner . Intervention 2: Control group:The placebo are tablets which will prepare like as C

Treatment - Drugs

Placebo

Intervention group:They will use oral tablet Cimi fugol daily for 8 weeks ,one tablet after dinner .

Control group:The placebo are tablets which will prepare like as Cimi fugol (shape and size) without effective drugs that will be given to participants with order of 1 tablet after dinner.

Eligibility

Sex/Gender

Female

Age

45 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: The age range is 45 to 60 years; During the past 12 months have not been menstural periods; With minimum score of 15 to maximum of 42 in Green score; Absence of disease or a history of breast cancer, uterine cancer, abnormal vaginal bleeding, liver disease, depression or hyperthyroidism (which must be approved by the medical center physician); have normal blood pressure(100/60 to 140/90); N0 use of hormonal or herbal drugs for relief of menopausal symptoms or other neurological drugs in the 2 past months or during the study; The lack of sensitivity to spices or essences; No-smoking and do not drinking alcohol. Exclusion criteria: medical complications during the study

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Vasomotor symptoms. Timepoint: One week befor and 4 and 8 weeks after intervention. Method of measurement: Green scale.;Psycological symptoms. Timepoint: One week befor and 4 and 8 weeks after intervention. Method of measurement: Green scale.;Added at 2013-06-01:Final Green score. Timepoint: Added at 2013-06-01: 4 & 8 weeks later after intervention. Method of measurement: Added at 2013-06-01: l Green score.	—

Measure

Time frame

Vasomotor symptoms. Timepoint: One week befor and 4 and 8 weeks after intervention. Method of measurement: Green scale.;Psycological symptoms. Timepoint: One week befor and 4 and 8 weeks after intervention. Method of measurement: Green scale.;Added at 2013-06-01:Final Green score. Timepoint: Added at 2013-06-01: 4 & 8 weeks later after intervention. Method of measurement: Added at 2013-06-01: l Green score.

—

Secondary

Measure	Time frame
Physical symptoms. Timepoint: One week befor and 4 and 8 weeks after intervention. Method of measurement: Green scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNahaee Jila

Tabriz University of Medical Sciences

jnahaee@yahoo.com+98 41 1477 2699

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Mar 22, 2026